3484 Laminaripentaose-producing beta-1,3-glucanase insertion domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organometallic compounds | 1 | 0.0 | 178× | not tested | |
| Mixed metal/non-metal compounds | 1 | 0.1 | 12× | not tested | |
| Organic oxygen compounds | 4 | 0.8 | 5.09× | not tested | |
| Organoheterocyclic compounds | 2 | 0.6 | 3.29× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09459 | TLA | L-tartaric acid | 28 |
| DB02159 | PGR | (R)-Propylene glycol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| TLA | L(+)-TARTARIC ACID | 34 |
| NAmetal | SODIUM ION | 2 |
| 6O0 | (1-butyl-3-methyl-1,3-dihydro-2H-imidazol-2-ylidene)(chloro)gold | 1 |
| 73M | bis(azanyl)-chloranyl-oxidanyl-platinum | 1 |
| CL | CHLORIDE ION | 1 |
| CPT | Cisplatin | 1 |
| I3C | 5-amino-2,4,6-triiodobenzene-1,3-dicarboxylic acid | 1 |
| IOD | IODIDE ION | 1 |
| Kmetal | POTASSIUM ION | 1 |
| PGR | R-1,2-PROPANEDIOL | 1 |
| SEY | selenourea | 1 |
| SRT | S,R MESO-TARTARIC ACID | 1 |
| TFX | 2-[4-(dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium | 1 |